Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(NY:
BLCO
)
16.43
+0.43 (+2.69%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about BLCO
< Previous
1
2
3
4
5
Next >
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
February 21, 2024
From
Emergent BioSolutions
Via
GlobeNewswire
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2023 Results and Provides 2024 Guidance
February 21, 2024
From
Bausch + Lomb Corporation
Via
Business Wire
Wall Street Waits With Bated Breath For Nvidia Earnings After Tech Selloff, Fed Minutes Eyed: Analyst Flags This As Biggest Risk For Market
February 21, 2024
The market will broaden the sustenance of its rally when interest-rate cuts begin to be priced in and investors begin to think about the roadmap, an analyst said.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Earnings Scheduled For February 21, 2024
February 21, 2024
Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million.
Via
Benzinga
Bausch & Lomb Earnings Preview
February 20, 2024
Via
Benzinga
The Latest Analyst Ratings for Bausch & Lomb
December 04, 2023
Via
Benzinga
Earnings Preview: What To Expect To When Eye Health Company Bausch + Lomb Reports Q4 Performance Later This Month
February 09, 2024
"Bausch + Lomb's Q4 & FY 2023 results on Feb 21, 2024. Expecting $1.107 billion in sales, $0.17 EPS. RBC Capital predicts $1.159 billion revenue. Insights on Miebo launch and enhanced EBITDA margins...
Via
Benzinga
Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2023 Financial Results on February 21
February 05, 2024
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Receives FDA Approval for TENEO™ Excimer Laser Platform for Myopia and Myopic Astigmatism LASIK Vision Correction Surgery
January 08, 2024
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch & Lomb Earnings Preview
October 31, 2023
Via
Benzinga
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
October 30, 2023
S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
6 Analysts Have This to Say About Bausch & Lomb
October 03, 2023
Via
Benzinga
Bausch + Lomb to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Reports More Than 76 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs
November 15, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Nasdaq, S&P 500 Futures Slide Ahead Of Fed Decision, Economic Data: Analyst Tells Why November Could Herald 'Good News'
November 01, 2023
U.S. stocks could start Wednesday's session lower as traders stay cautious ahead of the Fed decision and more earnings.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Bausch + Lomb Announces Third-Quarter 2023 Results and Raises Full-Year 2023 Guidance
November 01, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Will Present New Scientific Data and Analyses at American Academy of Ophthalmology Annual Meeting
October 26, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Will Release Third-Quarter 2023 Financial Results on November 1
October 16, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Will Present New Scientific Data and Analyses at American Academy of Optometry Annual Meeting
October 04, 2023
From
Bausch + Lomb
Via
Business Wire
Novartis Mulls Divesting Some Assets Of Radiopharma Unit In Strategic Shift
October 03, 2023
Swiss pharmaceutical giant Novartis AG (NYSE: NVS) is reportedly contemplating selling sections of radiopharmaceuticals company Advanced Accelerator Applications to align with the company's strategy...
Via
Benzinga
Bausch Health's Bausch + Lomb Announces Completion of the Acquisition of XIIDRA(R)
September 29, 2023
Via
ACCESSWIRE
Bausch + Lomb Completes Acquisition of XIIDRA®
September 29, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Launches LUMIFY EYE ILLUMINATIONS™ in the United States
September 26, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb’s ONE by ONE and Biotrue® Eye Care Recycling Programs Recognized As Sustainability Service of the Year Award Winners
September 20, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces Pricing of Senior Secured Notes Offering
September 14, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Launches MIEBO™ (Perfluorohexyloctane Ophthalmic Solution) in the United States
September 12, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch Health's Bausch + Lomb Announces Launch of Proposed Financing for Acquisition of XIIDRA(R)
September 11, 2023
Via
ACCESSWIRE
Bausch + Lomb Announces Launch of Proposed Financing for Acquisition of XIIDRA®
September 11, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Global Dry Eye Syndrome Treatment Market Expected to Reach $11.26 Billion By 2030
September 08, 2023
EQNX::TICKER_START (NASDAQ:OKYO),(NYSE:ALC),(NYSE:BLCO),(NYSE:JNJ),(OTCQX:RHHBY) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
COVID-19
Bausch + Lomb Announces Disclosure of Historical and Pro Forma Financial Information With Respect to Acquisition of XIIDRA®
September 06, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.